lansoprazole has been researched along with Muscular Dystrophy, Animal in 1 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Muscular Dystrophy, Animal: MUSCULAR DYSTROPHY that occurs in VERTEBRATE animals.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sali, A | 1 |
| Many, GM | 1 |
| Gordish-Dressman, H | 1 |
| van der Meulen, JH | 1 |
| Phadke, A | 1 |
| Spurney, CF | 1 |
| Cnaan, A | 1 |
| Hoffman, EP | 1 |
| Nagaraju, K | 1 |
1 other study available for lansoprazole and Muscular Dystrophy, Animal
| Article | Year |
|---|---|
The proton pump inhibitor lansoprazole improves the skeletal phenotype in dystrophin deficient mdx mice.
Topics: Animals; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Dystrophin; | 2013 |